Abstract | INTRODUCTION: Metagenomic Next-Generation Sequencing (mNGS) is an emerging technique for microbial identification and diagnosis of infectious diseases. The clinical utility of mNGS, especially its real-world impact on antimicrobial treatment and patient outcome has not been systematically evaluated. METHODS: We prospectively assessed the effectiveness of mNGS in 70 febrile inpatients with suspected infections at Hematology department of the Children's Hospital, National Clinical Research Center for Child Health. 69/70 patients were given empirical antibiotics prior to mNGS. A total of 104 samples (62 plasma, 34 throat swabs, 4 bone marrow, 4 bronchoalveolar lavage) were collected on day 1-28 (mean 6.9) following symptom onset and underwent mNGS testing. RESULTS: Traditional microbiological tests discovered causal microorganisms in 5/70 (7.14%) patients, which were also detected by mNGS. In addition, mNGS reported possible pathogens when routine tests were negative. Antibiotics were adjusted accordingly in 55/70 (78.6%) patients that led to improvement/relief of symptoms within 3 days. In contrast, mNGS results were considered irrelevant in 15/70 (21.4%) patients by a board of clinicians, based on biochemical, serological, imaging evidence, and experiences. CONCLUSION: mNGS expanded the capacity of pathogen detection and made a positive impact on clinical management of suspected infections through (a) differential diagnosis which may rule out infectious diseases and (b) adjustment or de-escalation of empirical antibiotics.
|
Authors | Heping Shen, Diying Shen, Hua Song, Xueqin Wu, Cong Xu, Guangyu Su, Chao Liu, Jingying Zhang |
Journal | International journal of laboratory hematology
(Int J Lab Hematol)
Vol. 43
Issue 2
Pg. 244-249
(Apr 2021)
ISSN: 1751-553X [Electronic] England |
PMID | 33099872
(Publication Type: Journal Article)
|
Copyright | © 2020 John Wiley & Sons Ltd. |
Chemical References |
|
Topics |
- Adolescent
- Biomarkers
- Child
- Child, Preschool
- Communicable Diseases
(diagnosis, etiology)
- Cross Infection
(diagnosis, etiology)
- Diagnostic Tests, Routine
- Disease Management
- Disease Susceptibility
- Female
- Hematologic Diseases
(complications)
- High-Throughput Nucleotide Sequencing
(methods)
- Humans
- Male
- Metagenome
- Metagenomics
(methods)
|